Literature DB >> 6321629

Regulation of B cell lymphomagenesis by a malignant Qal+ inducer T cell clone.

C L Reinisch, A P Sing, E R Bacon, R B Corley, R K Gershon.   

Abstract

A series of Thy-1.2+ Ly-1+ Qa-1+ malignant T cell clones have been isolated from murine sarcoma virus-murine leukemia-Moloney (MSV-MuLV-M)-induced B cell lymphomas or from MSV-MuLV-M-infected B6 mice. These T cell clones enhance both antigen-independent and -dependent lymphocyte differentiation and function. They also induce the differentiation of granulocytes and erythrocytes in the stem cell compartment, a function that parallels the immunopathology of the disease in vivo. The malignant T cell appears to sustain B lymphoma growth in vivo by releasing a factor (BCGF) that promotes B cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321629      PMCID: PMC2187257          DOI: 10.1084/jem.159.3.906

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  Spontaneous murine B-cell leukaemia.

Authors:  S Slavin; S Strober
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

2.  The role of mitogenic lectins in T-cell triggering.

Authors:  E L Larsson; A Coutinho
Journal:  Nature       Date:  1979-07-19       Impact factor: 49.962

3.  Replacement of T-cell function by a T-cell product.

Authors:  A Schimpl; E Wecker
Journal:  Nat New Biol       Date:  1972-05-03

4.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

5.  Immunoregulation of murine myeloma: isologous immunization with M315 induces idiotype-specific T cells that suppress IgA secretion by MOPC-315 cells in vivo.

Authors:  J W Rohrer; B Odermatt; R G Lynch
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

6.  Antigen-specific regulation of myeloma cell differentiation in vivo by carrier-specific T cell factors and macrophages.

Authors:  J W Rohrer; R G Lynch
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

7.  Amplification of granulopoiesis by T cell subpopulations.

Authors:  E R Bacon; A P Sing; C L Reinish
Journal:  Exp Hematol       Date:  1983-09       Impact factor: 3.084

8.  Proliferation of murine thymic lymphocytes in vitro is mediated by the concanavalin A-induced release of a lymphokine (costimulator).

Authors:  V Paetkau; G Mills; S Gerhart; V Monticone
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

9.  Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody.

Authors:  E S Vitetta; D Yuan; K Krolick; P Isakson; M Knapp; S Slavin; S Strober
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

10.  Immunoblastic sarcoma following Waldenström's macroglobulinemia.

Authors:  Y J Choi; G Yeh; L Reiner; A Spielvogel
Journal:  Am J Clin Pathol       Date:  1979-01       Impact factor: 2.493

View more
  2 in total

1.  Major histocompatibility complex class II-regulated immunity to murine leukemia virus protects against early T- but not late B-cell lymphomas.

Authors:  W L Vasmel; M Zijlstra; T Radaszkiewicz; C J Leupers; R E de Goede; C J Melief
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

2.  Murine models of B-cell lymphomas: promising tools for designing cancer therapies.

Authors:  Sabrina Donnou; Claire Galand; Valérie Touitou; Catherine Sautès-Fridman; Zsuzsanna Fabry; Sylvain Fisson
Journal:  Adv Hematol       Date:  2012-02-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.